Funds

2

Vintages

2025 to 2025

Reported GAV

$30.0Mgross asset value on Form ADV; never dry powder

Funds with fundraising evidence

0derived

Investments

0

Portfolio companies

0

Investments, 12m

0

Partner-attributed

0

People

3

Investment professionals

2derived

Co-investors

0derived

LP relationships

0

Latest Form D

Feb 4, 2026

Latest ADV filing

Dec 18, 2025

• Occurred

  Dec 18, 2025
  Adviser's first ADV filing

  108 Biocapital Growth Fund, LP appears on the SEC adviser roster (ERA, venture capital fund adviser exemption)

  Form ADVobserved 8 days ago

Also named here, with no published line of their own (reach them through the firm): Sasha Hassa Bakhru (Managing Partner & Ceo), Shom Haresh Jagtiani (Managing Partner), Steven Daniel Ward (Cfo).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Graph

Venture Capital

Canonical id

dfx:vc:8fe3343d-fbcb-4804-b882-b7e222e29b3a

First observed

Sep 12, 2026

Last observed

Sep 12, 2026 8 days ago

Source families

Federal regulator filings

2 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.

Resolution

Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.